Fu Wang
- Cancer Research top 5%
- MicroRNA in disease regulation 24
- Cancer-related molecular mechanisms research 10
- Biomaterials top 2%
- Molecular Biology top 5%
- Advanced biosensing and bioanalysis techniques 28
- RNA Interference and Gene Delivery 27
- CRISPR and Genetic Engineering 11
- RNA Research and Splicing 9
- RNA and protein synthesis mechanisms 8
- Pollution top 5%
- Biomedical Engineering top 5%
- Nanoplatforms for cancer theranostics 11
- Co-authors
- Sang Yup LeeChunyan LiuZheng XieHao ZhangXiaohong ChenBeilei ZhangGang NiuJie Tian
- Journals
- Analytical Chemistry (7 papers)ACS Nano (5 papers)Molecular Therapy — Nucleic Acids (4 papers)
- Partner nations
- ChinaUnited StatesSouth Korea
In The Last Decade
Fu Wang
159 papers receiving 4.0k citations
Hit Papers
Peers
Comparison fields: 5 of 164
- Cancer Research 598
- Biomaterials 511
- Molecular Biology 1.8k
- Pollution 251
- Biomedical Engineering 955
Countries citing papers authored by Fu Wang
This map shows the geographic impact of Fu Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fu Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fu Wang more than expected).
Fields of papers citing papers by Fu Wang
This network shows the impact of papers produced by Fu Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fu Wang. The network helps show where Fu Wang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Fu Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 2 | |
| 3 | 2025 | 1 | |
| 4 | 2025 | 0 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 3 | |
| 7 | 2024 | 1 | |
| 8 | 2024 | 2 | |
| 9 | 2024 | 2 | |
| 10 | 2024 | 18 | |
| 11 | 2023 | 5 | |
| 12 | 2023 | 3 | |
| 13 | 2023 | 7 | |
| 14 | 2023 | 17 | |
| 15 | 2018 | 10 | |
| 16 | 2014 | 50 | |
| 17 | Surveillance of antibiotic resistance in clinical isolates from Shanghai Huashan Hospital in 2005 | 2007 | 1 |
| 18 | Molecular Cloning and Characterization of a Glutathione S-transferase Gene Repressed by Phenylacetic Acid From Penicillium chrysogenum | 2006 | 3 |
| 19 | A randomized, patient-blind, multicenter comparison of gatifloxacin versus levofloxacin in the treatment of lower respiratory tract infections and urinary tract infections | 2003 | 1 |
| 20 | Taxoids from the Leaves and Stems of Taxus chinensis | 2003 | 1 |
About Fu Wang
Fu Wang is a scholar working on Cancer Research, Applied Microbiology and Biotechnology, Complementary and Manual Therapy, Orthodontics and Molecular Biology, having authored 172 papers that have together received 4.1k indexed citations. Recurring topics across this work include Advanced biosensing and bioanalysis techniques (28 papers), RNA Interference and Gene Delivery (27 papers), MicroRNA in disease regulation (24 papers), CRISPR and Genetic Engineering (11 papers), Nanoplatforms for cancer theranostics (11 papers), Cancer-related molecular mechanisms research (10 papers), RNA Research and Splicing (9 papers) and RNA and protein synthesis mechanisms (8 papers). The work is most often cited by research in Cancer Research (598 citations), Biomaterials (511 citations), Molecular Biology (1.8k citations), Pollution (251 citations) and Biomedical Engineering (955 citations). Fu Wang has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Sang Yup Lee, Chunyan Liu, Zheng Xie, Hao Zhang, Xiaohong Chen, Beilei Zhang, Gang Niu, Jie Tian, Dingbin Liu and Yaru Shi. Their work appears in journals such as Analytical Chemistry, ACS Nano, Molecular Therapy — Nucleic Acids, Scientific Reports and Food Chemistry X.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.